Global Strategic Investment Solutions’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-4,972
Closed -$255K 142
2022
Q4
$255K Buy
+4,972
New +$238K 0.02% 111
2022
Q3
Sell
-4,090
Closed -$214K 140
2022
Q2
$214K Sell
4,090
-1,337
-25% -$68.1K 0.02% 117
2022
Q1
$281K Buy
5,427
+74
+1% +$3.84K 0.02% 112
2021
Q4
$316K Buy
5,353
+665
+14% +$32.9K 0.05% 105
2021
Q3
$202K Sell
4,688
-500
-10% -$22.1K 0.03% 137
2021
Q2
$203K Sell
5,188
-1,900
-27% -$73.9K 0.03% 134
2021
Q1
$257K Buy
7,088
+1,000
+16% +$35.5K 0.05% 121
2020
Q4
$224K Sell
6,088
-932
-13% -$34.2K 0.05% 94
2020
Q3
$244K Buy
+7,020
New +$246K 0.06% 83

Other funds holding PFE

Global Strategic Investment Solutions's PFE Position: Q1 2023 in Review

Global Strategic Investment Solutions sold out of Pfizer (PFE) in Q1 2023, closing a stake of 4,972 shares — an estimated $255K sold.

Global Strategic Investment Solutions first reported a position in PFE in Q3 2020 and held it in 9 quarters. The position peaked at $316K in Q4 2021. 3,102 funds tracked by Wall St. Rank hold PFE as of Q1 2023.

  • Global Strategic Investment Solutions reported no remaining Pfizer position as of Q1 2023 after selling out during the quarter.
  • Global Strategic Investment Solutions sold 4,972 Pfizer shares in Q1 2023, an estimated $255K.
  • Global Strategic Investment Solutions first reported a position in Pfizer in Q3 2020 and held it in 9 quarters.
  • Global Strategic Investment Solutions's Pfizer position peaked at $316K in Q4 2021.
  • 3,102 funds tracked by Wall St. Rank held Pfizer as of Q1 2023.

Based on Global Strategic Investment Solutions's 13F filing for Q1 2023, filed 20 Apr 2023.